Perspectives & Insights

Explore our blog for valuable insights and inspiring stories from our team as we fulfill our vision to spark transformation in global health.

Apply filter
Filter

Filter

July 22, 2026
Corporate
Keys to Rebuilding Trust in Science and Other Takeaways from BIO
By Silvia Taylor, Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
Read post
June 24, 2026
Corporate
Partnerships
Research & Development
Building Immunity for the Future: Creating an R&D Innovation Engine to Fuel Partnerships at Novavax
By Elaine O’Hara, EVP, Chief Strategy Officer and Dr. Bob Walker, EVP, Head of Research & Development
Read post
April 30, 2026
Corporate
Research & Development
Matrix-M® Safety Data: An Interview with Jonathan Fix
Read post
Spring 2026
Corporate
Research & Development
Behind the Pipeline: The Benefits of Matrix-M®
Video featuring Karin Lövgren Bengtsson, PhD, Chief Scientist, Adjuvant CMC, and Jenny Reimer, PhD, MBA, Senior Director CMC Strategy and PMO
Read post
R&D Reflections from the Global Vaccine Stage Image Collage
Winter 2025
Research & Development
R&D Reflections from the Global Vaccine Stage
By Ruxandra Draghia-Akli, MD, PhD, EVP, Head of Research & Development
Read post
Fall 2025
Research & Development
Understanding Vaccine Terminology: Adjuvants, Protein-Based Nanoparticles and More
Read post

About Novavax

We tackle some of the world's most significant health challenges by leveraging our scientific expertise in vaccines and cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M® adjuvant.

Learn About Us